Literature DB >> 6404344

Effect of verapamil on enzyme release after early intravenous administration in acute myocardial infarction: double blind randomised trial.

L Thuesen, J R Jørgensen, H J Kvistgaard, J A Sørensen, M Vaeth, E B Jensen, J J Jensen, L Hagerup.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6404344      PMCID： PMC1547460          DOI： 10.1136/bmj.286.6371.1107

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  4 in total

1.  Experimental infarction studies.

Authors:  P R Maroko
Journal:  Clin Invest Med       Date:  1980       Impact factor: 0.825

2.  Clinical measurement of myocardial infarct size. Modification of a method for the estimation of total creatine phosphokinase release after myocardial infarction.

Authors:  R M Norris; R M Whitlock; C Barratt-Boyes; C W Small
Journal:  Circulation       Date:  1975-04       Impact factor: 29.690

3.  A protective effect of verapamil on hypoxic heart muscle.

Authors:  W G Nayler; A Grau; A Slade
Journal:  Cardiovasc Res       Date:  1976-11       Impact factor: 10.787

4.  Effects of verapamil on infarct size following experimental coronary occlusion.

Authors:  H J Smith; B N Singh; H D Nisbet; R M Norris
Journal:  Cardiovasc Res       Date:  1975-07       Impact factor: 10.787
  4 in total
  6 in total

Review 1.  Management of acute non-Q-wave myocardial infarction. The role of prophylactic diltiazem therapy and indications for predischarge coronary arteriography.

Authors:  R S Gibson
Journal:  Drugs       Date:  1991       Impact factor: 9.546

Review 2.  Calcium channel antagonists should be among the first-line drugs in the management of cardiovascular disease.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

3.  Calcium channel blockers in acute myocardial infarction and unstable angina: an overview.

Authors:  P H Held; S Yusuf; C D Furberg
Journal:  BMJ       Date:  1989-11-11

Review 4.  Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials.

Authors:  L H Opie
Journal:  Cardiovasc Drugs Ther       Date:  1988-01       Impact factor: 3.727

5.  Prolonged protective effect of the calcium antagonist anipamil on the ischemic reperfused rabbit myocardium: comparison with verapamil.

Authors:  R Ferrari; R Raddino; C Ceconi; S Curello; S Ghielmi; O Visioli
Journal:  Cardiovasc Drugs Ther       Date:  1989-06       Impact factor: 3.727

6.  Myocardial infarction: is bepridil, a new calcium antagonist, able to improve the course of the acute phase?

Authors:  D Flammang; M Waynberger; R Paillet; C Pruvot; G Cosson; A Chassing
Journal:  Cardiovasc Drugs Ther       Date:  1989-01       Impact factor: 3.727
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.